Khalid Ali Kambal, MBCHB

Khalid Kambal practices at Ridgeview Professional Building in Waconia, Minnesota.

Khalid Kambal's NPI, 1063513224, was assigned on September 26, 2006. Khalid Kambal holds Minnesota license 53593.

Khalid Kambal's primary practice is Ridgeview Professional Building, at 560 Maple S St, Waconia, MN 55387 in Carver County. The practice phone is (952) 442-2191.

Khalid Kambal's primary practice is Ridgeview Professional Building in Waconia, Minnesota. Khalid Kambal is also affiliated with Ridgeview Medical Center. The medical group on file is Minnesota Oncology. Dmand AI also links Khalid Kambal to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Khalid Kambal practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Khalid Kambal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Khalid Kambal's licenses on file in 3 states: Minnesota, Kentucky and Virginia.

CMS data shows 8,855 Medicare services from Khalid Kambal across 30 procedure codes in 2024, for 235 Medicare patients. Medicare paid $118,669 for them.

CMS counts 235 Medicare patients who saw Khalid Kambal in 2024. The largest group is 65 to 74, with 106 patients. 68% of them have high blood pressure, and 63% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Khalid Kambal's median patient age at 70, with 58% women.

In 2024, Khalid Kambal wrote 410 Medicare Part D claims for 102 patients. 83% of them were for generic drugs. CMS names the drug for 275 of them, across 13 drugs with 11 or more claims each, at $195,113 in total drug cost. In 2023, CMS named 428 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Khalid Kambal for performance year 2024, reported through an alternative payment model (APM). Khalid Kambal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Khalid Kambal as offering telehealth.

CMS Open Payments shows 2 general payments to Khalid Kambal from 1 drug or device company from 2020 to 2024. Education make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $35.